|
시장보고서
상품코드
1992128
전자 보철물 시장 : 기술 플랫폼별, 의지 종류별, 구성 요소별, 최종 사용자별 - 세계 예측(2026-2032년)Electronic Prostheses Market by Technology Platform, Prosthesis Type, Component, End User - Global Forecast 2026-2032 |
||||||
360iResearch
전자 보철물 시장은 2025년에 10억 3,000만 달러로 평가되었습니다. 2026년에는 11.54%의 CAGR로 11억 4,000만 달러로 확대해, 2032년까지 22억 2,000만 달러에 달할 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 10억 3,000만 달러 |
| 추정 연도(2026년) | 11억 4,000만 달러 |
| 예측 연도(2032년) | 22억 2,000만 달러 |
| CAGR(%) | 11.54% |
기술, 임상 도입, 규제 동향 및 이해관계자의 우선순위를 배경으로 설명한 현재 전자 의수족 시장에 대한 권위 있는 입문서
현재 전자 보철물의 현황은 감지, 작동, 제어 시스템 및 생체적합성 인터페이스의 발전이 임상 경로와 비즈니스 모델을 재구성하는 매우 중요한 전환점에 있습니다. 이 책은 디바이스 개발자, 부품 공급업체, 의료 제공자, 보험사, 규제 당국, 그리고 빠르게 변화하는 니즈를 가진 최종 사용자를 포함한 복잡한 생태계에 독자를 배치합니다. 이 책은 기술의 발전과 의료 서비스 제공 및 상환 관행의 변화를 종합적으로 검토함으로써, 지금이 왜 이해관계자들이 전략과 투자 우선순위를 재검토해야 하는 중요한 시기인지 밝힙니다.
신경근 인터페이스, 모듈형 아키텍처, 분산형 의료 제공 등 전자 보철물을 재구축하는 변화의 원동력에 대한 전략적 분석
전자 보철물 분야의 혁신적 변화는 감지, 제어 알고리즘, 재료 과학 분야의 급속한 역량 향상을 반영하고 있으며, 개인화 및 장기적인 지원을 강조하는 새로운 제공 모델과 함께 발전하고 있습니다. 새로운 신경근 인터페이스와 패턴 인식 시스템은 장치의 기능 범위를 확장하여 보다 자연스러운 제어와 직관적인 사용자 경험을 가능하게 합니다. 이는 임상적 기대와 재활 프로토콜도 변화시키고 있습니다. 동시에 모듈식 하드웨어 및 소프트웨어 아키텍처는 반복적인 업그레이드를 가능하게 하고, 혁신 주기를 단축시키며, 의료 시스템에서 조달에 대한 고려 사항을 변화시키고 있습니다.
최근 미국 관세 변경이 보철물 분야의 부품 조달, 공급망 전략 및 사업 계획에 미치는 누적적 영향에 대한 종합적인 평가
정책 수단과 관세 조정은 의료기기 제조업체와 공급업체에게 부품 조달, 공급망 탄력성 및 사업 계획에 중대한 영향을 미칠 수 있습니다. 최근 추세에 따라 제조업체들은 조달 전략을 다양화해야 하며, 무역 정책의 변동 위험을 줄이기 위해 니어쇼어링과 공급업체 중복화를 고려하고 있습니다. 이러한 변화는 재고 관리, 리드 타임, 공동 생산 계약에 영향을 미치고, 총착륙 비용과 공급업체와의 관계 구축 프레임워크를 재검토해야 할 필요성이 대두되고 있습니다.
기술 플랫폼, 보철물 유형, 핵심 부품, 최종 사용자 환경을 매핑한 상세한 세분화 정보를 통해 타겟팅된 제품 및 임상 전략 수립을 지원합니다.
정교한 세분화 프레임워크를 통해 기술 플랫폼, 보철물 유형, 구성 요소, 최종 사용자 환경에 걸쳐 다양한 혁신 및 상용화 경로를 파악할 수 있습니다. 기술 플랫폼에 따라 시장에는 신체 구동형 보철물, 미용용 보철물, 하이브리드 보철물, 근전도 보철물이 포함됩니다. 이를 더욱 세분화하면, 신체 구동형 보철물은 하네스 케이블식과 자립형 솔루션으로, 근전 보철물은 이식형 근전 보철물과 표면형 근전 보철물으로 구분됩니다. 또한, 이식형 근전기보철물의 분류에 있어서는 근내이식형과 골결합형 접근법이 구분됩니다. 이러한 구분은 편의성, 사용자 교육, 제어 충실도 측면에서 서로 다른 기술적 트레이드오프를 부각시켜 제품 포지셔닝 및 임상 경로를 결정하는 데 도움이 될 수 있습니다.
아메리카, 유럽, 중동 및 아프리카, 아시아태평양의 동향이 도입 경로, 상환, 공급 전략을 어떻게 형성하고 있는지 설명하는 전략적 지역 인사이트
각 지역마다 고유한 임상 관행, 상환 프레임워크, 공급망 구조가 존재하며, 각 지역의 동향은 전 세계 경쟁 우선순위와 개발 접근 방식을 형성하고 있습니다. 아메리카에서는 혁신 허브, 확립된 임상 네트워크, 강력한 민간 부문의 투자가 첨단 보철물 플랫폼에 대한 비옥한 토양을 조성하고 있지만, 지불자와 규제 환경은 확고한 임상적 증거와 입증 가능한 결과를 요구하고 있습니다. 이 지역의 이해관계자들은 기능적 결과 개선과 장기 치료 부담 감소를 입증하는 데이터 기반 솔루션을 우선시하고 있으며, 제조업체들은 임상시험 및 실제 데이터(REW) 프로그램을 현지 상환 기준에 맞게 조정할 것을 촉구하고 있습니다.
보철물 분야의 경쟁적 포지셔닝, 협업 동향, 기술 전문화, 시장 진입을 위한 필수 요건 등을 파악할 수 있는 기업 수준의 주요 인사이트
전자 보철물 분야의 경쟁 활동은 기존 의료기기 제조업체, 민첩한 틈새 분야의 혁신가, 부품 전문 제조업체, 임상 서비스 제공업체가 협업 생태계를 형성하는 다양한 구성이 특징입니다. 기존 장비 제조업체들은 모듈식 설계와 소프트웨어를 활용한 서비스로 제품 포트폴리오를 확장하고 있는 반면, 스타트업 기업들은 참신한 신경근 인터페이스, 경량 소재, 첨단 제어 알고리즘을 통해 한계를 뛰어넘고 있습니다. 액추에이터, 센서, 전원 시스템 전문 부품 공급업체들은 시장 출시 시간을 단축하는 턴키 어셈블리를 제공하기 위해 시스템 통합업체와 점점 더 많은 제휴를 맺고 있습니다.
모듈식 설계, 임상의와의 협력, 공급망 탄력성, 확장 가능한 서비스, 데이터 기반 증거 생성에 초점을 맞춘, 업계 리더를 위한 구체적인 제안
업계 리더는 기술적 가능성과 실용적 실행을 연결하고 지속가능한 가치를 얻기 위해 일련의 실행 가능한 조치를 우선시해야 합니다. 첫째, 제어 시스템, 센서, 전원공급장치 모듈을 단계적으로 업그레이드할 수 있는 상호 운용 가능한 아키텍처와 모듈형 플랫폼에 투자하여 제품 수명 주기를 연장하고 규제 대응 프로세스를 간소화할 수 있습니다. 둘째, 교육, 성과 추적, 지속적인 피드백 루프를 통합한 강력한 임상의 참여 프로그램을 구축하여, 기기가 실제 임상에서 기능적 요구를 충족하도록 보장하고, 장기적인 가치에 대한 지불자와의 대화를 지원합니다.
임상의와의 1차 인터뷰, 기기 사용성 검증, 2차 기술 분석, 시나리오 기반 스트레스 테스트를 결합한 엄격한 혼합 연구 방법론에 의한 조사 방법론
본 분석의 기반이 되는 조사 방법은 정성적 및 정량적 접근 방식을 결합하여 견고하고 다양한 시각을 확보할 수 있도록 했습니다. 1차 조사에서는 임상의, 보철치료사, 부품 공급업체 및 지불자를 대상으로 구조화된 인터뷰를 실시하여 사용성, 조달 동향 및 임상 워크플로우에 대한 일선 현장의 관점을 파악했습니다. 이러한 인터뷰는 현장 관찰과 기기 사용성 평가로 보완되어 일반적인 치료 환경에서 착용감, 편안함, 유지보수 요구사항에 대한 주장을 검증했습니다.
지속가능한 도입과 장기적인 영향력을 실현하기 위해 혁신, 임상적 증거, 서비스 우수성의 일관성 확보의 필요성을 강조하는 결론적 통합
이러한 통합 분석은 전자 보철물이 틈새시장과 기능 중심의 혁신에서 제품 설계, 임상 협력, 상업적 운영 전반에 걸친 협력적 전략이 필요한 통합 솔루션으로 전환되고 있음을 다시 한번 보여줍니다. 이 시대의 성공은 기술적 의사결정을 실제 워크플로우와 일치시키고, 보험사와 임상의가 공감할 수 있는 증거 창출 경로를 구축하며, 지속적인 사용자 성과를 보장하는 서비스 모델을 개발하는 데 달려있습니다. 기술적 우수성, 규제 준수, 운영상의 타당성 요건을 조화시킴으로써 이해관계자들은 새로운 도입과 영향력을 창출할 수 있는 새로운 길을 열 수 있습니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 미국의 관세 누적 영향(2025년)
제7장 AI의 누적 영향(2025년)
제8장 전자 보철물 시장 : 기술 플랫폼별
제9장 전자 보철물 시장 : 보철물 종류별
제10장 전자 보철물 시장 : 구성 요소별
제11장 전자 보철물 시장 : 최종 사용자별
제12장 전자 보철물 시장 : 지역별
제13장 전자 보철물 시장 : 그룹별
제14장 전자 보철물 시장 : 국가별
제15장 미국의 전자 보철물 시장
제16장 중국의 전자 보철물 시장
제17장 경쟁 구도
KTH 26.04.20The Electronic Prostheses Market was valued at USD 1.03 billion in 2025 and is projected to grow to USD 1.14 billion in 2026, with a CAGR of 11.54%, reaching USD 2.22 billion by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.03 billion |
| Estimated Year [2026] | USD 1.14 billion |
| Forecast Year [2032] | USD 2.22 billion |
| CAGR (%) | 11.54% |
An authoritative introduction to the current electronic prostheses landscape that contextualizes technology, clinical adoption, regulatory dynamics, and stakeholder priorities
The electronic prostheses landscape is at a pivotal juncture where advances in sensing, actuation, control systems, and biocompatible interfaces are reshaping clinical pathways and commercial models. This introduction situates readers within a complex ecosystem that includes device innovators, component suppliers, clinical providers, payers, regulatory authorities, and end users whose needs are rapidly evolving. By synthesizing technological progress alongside shifts in care delivery and reimbursement practice, the narrative frames why now is a critical moment for stakeholders to reassess strategy and investment priorities.
As we move from prototype to scalable deployment, the interplay between human-centered design, durability, and seamless clinical integration becomes a central concern. Regulatory clarity and device interoperability are becoming as important as raw device capability, and long-term user outcomes are increasingly prioritized by clinicians and procurement teams. Consequently, product roadmaps and go-to-market strategies must align more closely with clinical workflows, training ecosystems, and lifecycle service models to ensure sustained adoption and real-world impact.
A strategic analysis of the transformative forces reshaping electronic prostheses including neuromuscular interfaces, modular architectures, and decentralized care delivery
Transformative shifts in the electronic prostheses sector reflect an acceleration of capabilities across sensing, control algorithms, and materials science, paired with new delivery models that emphasize personalization and longitudinal support. Emerging neuromuscular interfaces and pattern recognition systems are expanding the functional envelope of devices, enabling more naturalistic control and intuitive user experiences that in turn alter clinical expectations and rehabilitation protocols. Concurrently, modular hardware and software architectures are enabling iterative upgrades, shortening innovation cycles and changing procurement considerations for health systems.
Another major shift is the decentralization of care pathways. Remote tuning, tele-rehabilitation, and community-based specialty clinics are allowing users to receive ongoing optimization outside traditional hospital settings. This trend is reshaping value propositions: companies must now account for lifetime service models, data-driven performance monitoring, and cybersecurity safeguards as part of their core offerings. Finally, cross-industry collaborations-pairing biomechanics expertise with advances in battery and sensor technology-are generating multi-disciplinary solutions that break legacy silos and create new partnership opportunities.
Comprehensive assessment of the cumulative effects of recent United States tariff changes on component sourcing, supply chain strategies, and commercial planning in prosthetics
Policy instruments and tariff adjustments can materially influence component sourcing, supply chain resiliency, and commercial planning for device manufacturers and suppliers. Recent tariff developments have compelled manufacturers to diversify procurement strategies and evaluate nearshoring or supplier redundancy to mitigate exposure to trade policy volatility. These shifts have implications for inventory management, lead times, and collaborative manufacturing agreements, prompting a reassessment of total landed cost and supplier relationship frameworks.
As stakeholders respond to tariff-driven pressures, design-for-manufacture and alternative materials selection are gaining prominence. Firms are recalibrating product architectures to reduce dependence on tariff-exposed inputs, while supply chain teams are enhancing scenario planning capabilities to maintain continuity of care and product availability. In parallel, the clinical and distribution networks are adapting contract terms and procurement cadences to accommodate potential price variability, reinforcing the need for flexible commercial agreements and transparent cost communication between manufacturers, health systems, and payers.
In-depth segmentation insights that map technology platforms, prosthesis types, critical components, and end-user settings to drive targeted product and clinical strategies
A nuanced segmentation framework reveals multiple pathways for innovation and commercialization across technology platforms, prosthesis types, components, and end-user settings. Based on Technology Platform, the market includes Body Powered Prostheses, Cosmetic Prostheses, Hybrid Prostheses, and Myoelectric Prostheses, with further differentiation such that Body Powered Prostheses are examined as Harnessed Cable and Self Contained solutions, while Myoelectric Prostheses are delineated into Implantable Myoelectric and Surface Myoelectric categories; the Implantable Myoelectric classification further distinguishes between Intramuscular Implant and Osseointegration Implant approaches. These distinctions highlight divergent engineering trade-offs between simplicity, user training, and fidelity of control, informing product positioning and clinical pathways.
Based on Prosthesis Type, offerings range across Lower Limb Prostheses, Multifunctional Prostheses, and Upper Limb Prostheses. Within Lower Limb Prostheses, designers must navigate subsegments including Foot Prostheses, Hip Prostheses, and Knee Prostheses, and Foot Prostheses themselves diversify into Articulated Prosthesis, Energy Storage And Return, and Hydraulic Prosthesis solutions. Hip Prostheses separate into Modular Prosthesis and Non Modular Prosthesis configurations, while Knee Prostheses span Mechanical Prosthesis, Microprocessor Controlled Prosthesis, and Polycentric Prosthesis alternatives. Upper Limb Prostheses incorporate Elbow Prostheses, Hand Prostheses, Shoulder Prostheses, and Wrist Prostheses, with Hand Prostheses further categorized as Body Powered Hand, Hybrid Hand, and Myoelectric Hand. These layered distinctions carry implications for rehabilitation protocols, component selection, and clinical training needs.
Based on Component, attention focuses on Actuator, Control System, Power Source, Sensor, and Socket elements. Actuator choices include Electric Actuator, Hydraulic Actuator, and Pneumatic Actuator, and Control System options encompass Microprocessor Controlled System, Neuromuscular Interface, and Pattern Recognition System approaches. Power Source considerations weigh Battery against Fuel Cell technologies, while Sensor strategies compare Myoelectric Sensor, Position Sensor, and Pressure Sensor capabilities. Socket design alternatives include Adjustable Socket, Custom Laminated Socket, and Thermoplastic Socket, each presenting trade-offs in comfort, fit, and serviceability. Finally, Based on End User, distribution and service models must account for Home Care Settings, Hospitals, Rehabilitation Centers, and Specialty Clinics as distinct channels with unique procurement, training, and reimbursement dynamics. Together, this segmentation mosaic informs targeted product development, clinical evidence generation, and go-to-market tailoring for varied user journeys.
Strategic regional insights explaining how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape adoption pathways, reimbursement, and supply strategies
Regional dynamics are shaping competitive priorities and deployment approaches across the globe, each region presenting particular clinical practices, reimbursement frameworks, and supply chain architectures. In the Americas, innovation hubs, established clinical networks, and strong private-sector investment create fertile ground for advanced prosthetic platforms, while payer and regulatory environments demand robust clinical evidence and demonstrable outcomes. Stakeholders here are prioritizing data-driven solutions that demonstrate improved functional outcomes and reduced long-term care burden, prompting manufacturers to align clinical trials and real-world evidence programs with local reimbursement standards.
Across Europe, Middle East & Africa, regulatory harmonization efforts and varied healthcare delivery models create a mosaic of adoption pathways. In several countries, public procurement levers and centralized purchasing can accelerate scaled deployments when clinical and economic value is clearly articulated. Regional partnerships and manufacturing collaborations are being used to adapt devices to diverse clinical settings and to manage cross-border logistics. In the Asia-Pacific region, market dynamics feature a mix of rapidly growing demand, manufacturing capacity expansion, and differing clinical infrastructures. This region is an important arena for cost-sensitive design, localized manufacturing strategies, and partnerships that adapt service models to community healthcare contexts. Collectively, these regional insights underscore the importance of adaptive commercial approaches, localized evidence generation, and supply chain strategies tailored to regional operational realities.
Key company-level insights revealing collaboration trends, technology specialization, and go-to-market imperatives that define competitive positioning in prosthetics
Competitive activity in the electronic prostheses arena is characterized by a heterogeneous mix of established medical device manufacturers, agile niche innovators, component specialists, and clinical service providers forming ecosystems of collaboration. Incumbent device makers are extending portfolios with modular designs and software-enabled services, while startups are pushing boundaries with novel neuromuscular interfaces, lightweight materials, and advanced control algorithms. Component suppliers focused on actuators, sensors, and power systems are increasingly partnering with systems integrators to deliver turnkey assemblies that accelerate time-to-market.
Strategic partnerships, licensing arrangements, and targeted acquisitions are common as companies seek to secure technological differentiators and distribution reach. Meanwhile, clinical and academic collaborations are driving validation studies and human factors research that strengthen device claims and support clinician adoption. Service providers and specialty clinics are emerging as critical channels for post-fitting optimization and data collection, reinforcing the importance of long-term service contracts and digital support platforms. For industry participants, the strategic imperative is to combine product excellence with scalable service models and credible clinical evidence to sustain commercial momentum.
Actionable recommendations for industry leaders focused on modular design, clinician engagement, supply chain resilience, scalable services, and data-driven evidence generation
Industry leaders should prioritize a set of actionable moves that bridge technological promise with operational execution to capture durable value. First, invest in interoperable architectures and modular platforms that enable incremental upgrades to control systems, sensors, and power modules, thus extending product lifecycles and simplifying regulatory pathways. Second, build robust clinician engagement programs that integrate training, outcomes tracking, and continuous feedback loops to ensure devices meet real-world functional needs and to support payer conversations about long-term value.
Third, strengthen supply chain resilience by diversifying suppliers, exploring regional manufacturing partnerships, and adopting design-for-manufacture approaches that reduce exposure to tariff and logistics volatility. Fourth, develop scalable service models that include remote monitoring, tele-rehabilitation, and local specialist networks to support ongoing optimization and minimize displacement risk. Fifth, adopt a data-first approach to evidence generation: prioritize real-world data capture, standardized clinical metrics, and transparent reporting to accelerate reimbursement discussions and improve product iteration. Collectively, these recommendations offer a pragmatic roadmap for converting technical capability into sustained clinical adoption and commercial performance.
A rigorous mixed-methods research methodology combining primary clinician interviews, device usability validation, secondary technical analysis, and scenario stress-testing
The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure robust, triangulated insights. Primary research included structured interviews with clinicians, prosthetists, component suppliers, and payers to surface first-hand perspectives on usability, procurement dynamics, and clinical workflows. These interviews were complemented by field observations and device usability assessments to validate claims around fit, comfort, and maintenance requirements in representative care environments.
Secondary research drew on peer-reviewed literature, regulatory filings, patent disclosures, and manufacturer technical documentation to map technology maturity and component interdependencies. Market signals were cross-validated through supplier tender data, distribution channel analysis, and case studies of clinical implementation. Finally, findings were subjected to iterative expert review and stress testing across alternative scenarios to ensure resilience of conclusions and to identify key sensitivities. Limitations include variability in clinical reporting standards and heterogeneity in care delivery models, which were mitigated by a focus on reproducible performance metrics and stakeholder consensus.
A conclusive synthesis emphasizing the need to align innovation, clinical evidence, and service excellence to achieve sustainable adoption and long-term impact
This concluding synthesis reiterates that electronic prostheses are transitioning from niche, capability-driven innovations to integrated solutions that require coordinated strategies across product design, clinical engagement, and commercial operations. Success in this era depends on aligning engineering decisions with real-world workflows, constructing evidence-generation pathways that resonate with payers and clinicians, and developing service models that ensure sustained user outcomes. By reconciling the imperatives of technical excellence, regulatory compliance, and operational feasibility, stakeholders can unlock new pathways for adoption and impact.
Looking ahead, the interplay between human-centered interface design, modular hardware, and continuous software improvement will define competitive advantage. Firms that pair differentiated technology with credible longitudinal outcomes and scalable post-market support will be best positioned to influence care standards and to capture clinical preference. Ultimately, a pragmatic balance of innovation velocity and demonstrable clinical value will determine which solutions become integral components of rehabilitation and assistive care pathways.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Porter's Five Forces Analysis
- 4.4. PESTLE Analysis
- 4.5. Market Outlook
- 4.5.1. Near-Term Market Outlook (0-2 Years)
- 4.5.2. Medium-Term Market Outlook (3-5 Years)
- 4.5.3. Long-Term Market Outlook (5-10 Years)
- 4.6. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Electronic Prostheses Market, by Technology Platform
- 8.1. Body Powered Prostheses
- 8.1.1. Harnessed Cable
- 8.1.2. Self Contained
- 8.2. Cosmetic Prostheses
- 8.3. Hybrid Prostheses
- 8.4. Myoelectric Prostheses
- 8.4.1. Implantable Myoelectric
- 8.4.1.1. Intramuscular Implant
- 8.4.1.2. Osseointegration Implant
- 8.4.2. Surface Myoelectric
- 8.4.1. Implantable Myoelectric
9. Electronic Prostheses Market, by Prosthesis Type
- 9.1. Lower Limb Prostheses
- 9.1.1. Foot Prostheses
- 9.1.1.1. Articulated Prosthesis
- 9.1.1.2. Energy Storage And Return
- 9.1.1.3. Hydraulic Prosthesis
- 9.1.2. Hip Prostheses
- 9.1.2.1. Modular Prosthesis
- 9.1.2.2. Non Modular Prosthesis
- 9.1.3. Knee Prostheses
- 9.1.3.1. Mechanical Prosthesis
- 9.1.3.2. Microprocessor Controlled Prosthesis
- 9.1.3.3. Polycentric Prosthesis
- 9.1.1. Foot Prostheses
- 9.2. Multifunctional Prostheses
- 9.3. Upper Limb Prostheses
- 9.3.1. Elbow Prostheses
- 9.3.2. Hand Prostheses
- 9.3.2.1. Body Powered Hand
- 9.3.2.2. Hybrid Hand
- 9.3.2.3. Myoelectric Hand
- 9.3.3. Shoulder Prostheses
- 9.3.4. Wrist Prostheses
10. Electronic Prostheses Market, by Component
- 10.1. Actuator
- 10.1.1. Electric Actuator
- 10.1.2. Hydraulic Actuator
- 10.1.3. Pneumatic Actuator
- 10.2. Control System
- 10.2.1. Microprocessor Controlled System
- 10.2.2. Neuromuscular Interface
- 10.2.3. Pattern Recognition System
- 10.3. Power Source
- 10.3.1. Battery
- 10.3.2. Fuel Cell
- 10.4. Sensor
- 10.4.1. Myoelectric Sensor
- 10.4.2. Position Sensor
- 10.4.3. Pressure Sensor
- 10.5. Socket
- 10.5.1. Adjustable Socket
- 10.5.2. Custom Laminated Socket
- 10.5.3. Thermoplastic Socket
11. Electronic Prostheses Market, by End User
- 11.1. Home Care Settings
- 11.2. Hospitals
- 11.3. Rehabilitation Centers
- 11.4. Specialty Clinics
12. Electronic Prostheses Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
13. Electronic Prostheses Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
14. Electronic Prostheses Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
15. United States Electronic Prostheses Market
16. China Electronic Prostheses Market
17. Competitive Landscape
- 17.1. Market Concentration Analysis, 2025
- 17.1.1. Concentration Ratio (CR)
- 17.1.2. Herfindahl Hirschman Index (HHI)
- 17.2. Recent Developments & Impact Analysis, 2025
- 17.3. Product Portfolio Analysis, 2025
- 17.4. Benchmarking Analysis, 2025
- 17.5. Aesthetic Prosthetics Inc.
- 17.6. Artificial Limbs & Appliances Pty Ltd.
- 17.7. Blatchford Limited
- 17.8. Coapt LLC
- 17.9. COVVI Ltd.
- 17.10. DeeDee Labs Pvt Limited
- 17.11. Ekso Bionics Holdings Inc.
- 17.12. Fillauer Companies, Inc. by Hanger, Inc.
- 17.13. HDT Global, Inc.
- 17.14. Human Technology Inc.
- 17.15. Lifeward
- 17.16. Maxon Group
- 17.17. Mobius Bionics
- 17.18. Open Bionics
- 17.19. Ottobock SE & Co. KGaA
- 17.20. RSL Steeper Group by Eqwal Group
- 17.21. Shadow Robot Company
- 17.22. Steeper Group
- 17.23. Trulife
- 17.24. Unlimited Tomorrow
- 17.25. WillowWood Global LLC
- 17.26. Xilloc Medical
- 17.27. Ossur Americas, Inc.
